VanEck Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.5M Sell
1,045,605
-1,275,287
-55% -$21.4M 0.02% 352
2025
Q1
$35.7M Buy
2,320,892
+705,197
+44% +$10.8M 0.05% 233
2024
Q4
$35.6M Sell
1,615,695
-259,692
-14% -$5.72M 0.05% 224
2024
Q3
$34.5M Buy
1,875,387
+208,673
+13% +$3.84M 0.04% 223
2024
Q2
$27.1M Buy
1,666,714
+119,730
+8% +$1.95M 0.04% 234
2024
Q1
$21.8M Sell
1,546,984
-395,458
-20% -$5.58M 0.03% 252
2023
Q4
$20.3M Sell
1,942,442
-323,647
-14% -$3.38M 0.04% 238
2023
Q3
$23.1M Sell
2,266,089
-300,333
-12% -$3.06M 0.05% 216
2023
Q2
$19.3M Buy
2,566,422
+892,702
+53% +$6.72M 0.04% 248
2023
Q1
$14.8M Sell
1,673,720
-969,380
-37% -$8.58M 0.03% 289
2022
Q4
$24.1M Buy
2,643,100
+348,658
+15% +$3.18M 0.06% 219
2022
Q3
$18.5M Sell
2,294,442
-919,292
-29% -$7.42M 0.06% 232
2022
Q2
$24.2M Buy
3,213,734
+1,324,951
+70% +$9.96M 0.06% 223
2022
Q1
$17.7M Sell
1,888,783
-23,543
-1% -$221K 0.04% 271
2021
Q4
$15.3M Buy
1,912,326
+305,004
+19% +$2.44M 0.04% 294
2021
Q3
$15.7M Buy
1,607,322
+390,180
+32% +$3.8M 0.04% 284
2021
Q2
$12.1M Buy
1,217,142
+404,483
+50% +$4M 0.03% 318
2021
Q1
$9.38M Sell
812,659
-251,624
-24% -$2.9M 0.03% 354
2020
Q4
$10.3M Sell
1,064,283
-133,002
-11% -$1.28M 0.03% 306
2020
Q3
$10.8M Buy
1,197,285
+316,201
+36% +$2.85M 0.03% 252
2020
Q2
$10.9M Sell
881,084
-48,010
-5% -$592K 0.04% 244
2020
Q1
$8.34M Buy
929,094
+41,269
+5% +$371K 0.04% 246
2019
Q4
$8.7M Buy
887,825
+210,525
+31% +$2.06M 0.03% 281
2019
Q3
$4.66M Sell
677,300
-210,457
-24% -$1.45M 0.02% 351
2019
Q2
$8.19M Buy
887,757
+352,843
+66% +$3.26M 0.04% 254
2019
Q1
$8.39M Sell
534,914
-66,001
-11% -$1.03M 0.04% 239
2018
Q4
$9.27M Buy
600,915
+44,349
+8% +$684K 0.05% 231
2018
Q3
$12M Sell
556,566
-30,678
-5% -$661K 0.06% 231
2018
Q2
$14.3M Sell
587,244
-14,369
-2% -$349K 0.07% 206
2018
Q1
$10.3M Sell
601,613
-255,485
-30% -$4.37M 0.05% 233
2017
Q4
$16.2M Buy
857,098
+49,777
+6% +$943K 0.08% 194
2017
Q3
$14.2M Buy
807,321
+370,380
+85% +$6.52M 0.07% 208
2017
Q2
$14.5M Sell
436,941
-29,945
-6% -$995K 0.08% 196
2017
Q1
$15M Buy
466,886
+129,691
+38% +$4.16M 0.07% 193
2016
Q4
$12.2M Buy
337,195
+123,331
+58% +$4.47M 0.06% 192
2016
Q3
$9.84M Sell
213,864
-9,928
-4% -$457K 0.05% 214
2016
Q2
$11.2M Buy
223,792
+19,078
+9% +$958K 0.06% 191
2016
Q1
$11M Sell
204,714
-44,405
-18% -$2.38M 0.07% 165
2015
Q4
$16.4M Buy
249,119
+8,920
+4% +$586K 0.13% 151
2015
Q3
$13.6M Sell
240,199
-47,378
-16% -$2.68M 0.1% 161
2015
Q2
$17M Buy
287,577
+57,685
+25% +$3.41M 0.1% 165
2015
Q1
$14.3M Sell
229,892
-1,221
-0.5% -$76.1K 0.08% 183
2014
Q4
$13.3M Sell
231,113
-41,965
-15% -$2.41M 0.08% 181
2014
Q3
$14.7M Sell
273,078
-18,485
-6% -$994K 0.08% 174
2014
Q2
$15.3M Buy
291,563
+3,590
+1% +$188K 0.07% 170
2014
Q1
$15.2M Buy
287,973
+2,515
+0.9% +$133K 0.08% 161
2013
Q4
$11.4M Buy
285,458
+5,054
+2% +$203K 0.06% 176
2013
Q3
$10.6M Buy
280,404
+3,224
+1% +$122K 0.05% 171
2013
Q2
$10.9M Buy
+277,180
New +$10.9M 0.06% 163